The study demonstrated that miR-208a/Med13 axis in cardiac muscle was involved in regulating the energy homeostasis in distant organs, including fat tissue and liver, and indicated that miR-208a could be a promising therapeutic target for metabolic disorders such as type 2 diabetes and obesity (Figures 2, 3). The gene discussed is MED13; the disease is Obesity.